FDA issues warning on E-cigarette liquids resembling cough syrup

FDA issues warning on E-cigarette liquids resembling cough syrup

(HealthDay)—Warning letters have been sent to two companies that make and sell electronic cigarette liquids that look like prescription cough syrups, the U.S. Food and Drug Administration said Thursday.

The identified in the warning letters to Undisputed Worldwide and EZ Fumes include: Double Cup Liquids Spritech Lemon Lime E-Juice Syrup and Double Cup Liquids Pineapple Phantom E-Juice Syrup e-liquid products. They have labeling and advertising that imitate the prescription cough syrup products Actavis Prometh with Codeine and Hi-Tech Promethazine Hydrochloride and Codeine, respectively, according to the FDA.

"By deliberately making or selling e-liquid products that look like prescription cough syrups, these companies are putting adults and children at risk of nicotine poisoning. The products are being designed in ways that make them falsely appear to be ingestible. These actions are egregious," FDA Commissioner Scott Gottlieb, M.D., said in an agency news release. "The products not only use labeling with statements, representations and graphical elements that imitate legitimate cough medications, but they also have a list of ingredients that mimics a drug facts label."

There has been a recent surge in child poisonings due to consumption of liquid nicotine. Small children who consume liquid nicotine can suffer severe harm, including death from , as well as seizure, coma, and respiratory arrest, the FDA said.


Explore further

FDA bans e-cig liquid products that look like snacks, candies

More information: More Information

Copyright © 2019 HealthDay. All rights reserved.

Citation: FDA issues warning on E-cigarette liquids resembling cough syrup (2019, April 5) retrieved 16 October 2019 from https://medicalxpress.com/news/2019-04-fda-issues-e-cigarette-liquids-resembling.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more